Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA - PubMed (original) (raw)
doi: 10.1038/ncb2039. Epub 2010 Mar 21.
Shenglin Huang, Shunquan Wu, Yingjun Zhao, Linhui Liang, Mingxia Yan, Chao Ge, Jian Yao, Taoyang Chen, Dafang Wan, Hongyang Wang, Jianren Gu, Ming Yao, Jinjun Li, Hong Tu, Xianghuo He
Affiliations
- PMID: 20305651
- DOI: 10.1038/ncb2039
Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA
Jie Ding et al. Nat Cell Biol. 2010 Apr.
Abstract
Recurrent chromosomal aberrations are often observed in hepatocellular carcinoma (HCC), but little is known about the functional non-coding sequences, particularly microRNAs (miRNAs), at the chromosomal breakpoints in HCC. Here we show that 22 miRNAs are often amplified or deleted in HCC. MicroRNA-151 (miR-151), a frequently amplified miRNA on 8q24.3, is correlated with intrahepatic metastasis of HCC. We further show that miR-151, which is often expressed together with its host gene FAK, encoding focal adhesion kinase, significantly increases HCC cell migration and invasion in vitro and in vivo, mainly through miR-151-5p, but not through miR-151-3p. Moreover, miR-151 exerts this function by directly targeting RhoGDIA, a putative metastasis suppressor in HCC, thus leading to the activation of Rac1, Cdc42 and Rho GTPases. In addition, miR-151 can function synergistically with FAK to enhance HCC cell motility and spreading. Thus, our findings indicate that chromosome gain of miR-151 is a crucial stimulus for tumour invasion and metastasis of HCC.
Comment in
Similar articles
- MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC, Huang XH. Chen JS, et al. Cancer Lett. 2016 May 28;375(1):73-83. doi: 10.1016/j.canlet.2016.02.043. Epub 2016 Mar 2. Cancer Lett. 2016. PMID: 26944318 - MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y, Du J, Liu Z, Zhang D, Yao X, Yang Y. Xie Y, et al. J Exp Clin Cancer Res. 2019 Jan 8;38(1):7. doi: 10.1186/s13046-018-1020-z. J Exp Clin Cancer Res. 2019. PMID: 30621734 Free PMC article. - microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
Shi X, Liu TT, Yu XN, Balakrishnan A, Zhu HR, Guo HY, Zhang GC, Bilegsaikhan E, Sun JL, Song GQ, Weng SQ, Dong L, Ott M, Zhu JM, Shen XZ. Shi X, et al. Oncogene. 2020 Aug;39(35):5768-5781. doi: 10.1038/s41388-020-01401-0. Epub 2020 Jul 27. Oncogene. 2020. PMID: 32719439 - Overexpressed or hyperactivated Rac1 as a target to treat hepatocellular carcinoma.
Sauzeau V, Beignet J, Vergoten G, Bailly C. Sauzeau V, et al. Pharmacol Res. 2022 May;179:106220. doi: 10.1016/j.phrs.2022.106220. Epub 2022 Apr 9. Pharmacol Res. 2022. PMID: 35405309 Review.
Cited by
- Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53.
Ou WB, Lu M, Eilers G, Li H, Ding J, Meng X, Wu Y, He Q, Sheng Q, Zhou HM, Fletcher JA. Ou WB, et al. Br J Cancer. 2016 Nov 8;115(10):1253-1263. doi: 10.1038/bjc.2016.331. Epub 2016 Oct 13. Br J Cancer. 2016. PMID: 27736841 Free PMC article. - m6A-dependent mature miR-151-5p accelerates the malignant process of HNSCC by targeting LYPD3.
Huang F, Ren Y, Hua Y, Wang Y, Li R, Ji N, Zeng X, Bai D, Chen Q, Zhou X, Wu J, Li J. Huang F, et al. Mol Biomed. 2024 Jul 16;5(1):27. doi: 10.1186/s43556-024-00189-9. Mol Biomed. 2024. PMID: 39009906 Free PMC article. - Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.
Bi Q, Tang S, Xia L, Du R, Fan R, Gao L, Jin J, Liang S, Chen Z, Xu G, Nie Y, Wu K, Liu J, Shi Y, Ding J, Fan D. Bi Q, et al. PLoS One. 2012;7(6):e40169. doi: 10.1371/journal.pone.0040169. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768249 Free PMC article. - Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.
Farrell J, Petrovics G, McLeod DG, Srivastava S. Farrell J, et al. Int J Mol Sci. 2013 Jul 25;14(8):15510-31. doi: 10.3390/ijms140815510. Int J Mol Sci. 2013. PMID: 23892597 Free PMC article. Review. - MicroRNAs in liver disease.
Szabo G, Bala S. Szabo G, et al. Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):542-52. doi: 10.1038/nrgastro.2013.87. Epub 2013 May 21. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23689081 Free PMC article. Review.
References
- Gastroenterology. 2000 Aug;119(2):431-40 - PubMed
- Hepatogastroenterology. 2004 Jan-Feb;51(55):186-91 - PubMed
- Mol Cell. 2004 Jul 2;15(1):117-27 - PubMed
- Nat Genet. 2003 Aug;34(4):369-76 - PubMed
- J Immunol. 2006 Dec 15;177(12):8512-21 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous